Today on DrugResearcher.com   Small molecules still leading the way into the clinic Pfizer buys CovX to bulk biologics pipeline Biochips help reduce the need for animal testing New drug on the blocks for athletes Mapping the 'human embryome' in BioTime

Related Industry News   Consort Medical feeling the loss of Exubera Flamel tech used for Merck Serono drug MDS Pharma continues efforts to move on from FDA review Merck inks multi-million dollar deal with Cognizant

Breaking News on Drug Discovery
Daily  Thursday 20 December 2007		Forward to a colleague

	Access Full Stories Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007... Read Pfizer buys CovX to bulk biologics pipeline Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs... Read Biochips help reduce the need for animal testing US researchers have developed a new biochip technology that could dramatically reduce the need for animal testing during drug development safety studies... Read New drug on the blocks for athletes Scientists have discovered a potential new drug target that will prick up the ears of sportsmen and athletes alike. Not that this is an performance-enhancing drug; instead, it could help athletes recover from injury... Read Mapping the 'human embryome' in BioTime BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem cells... Read
	All News Headlines for: December | November | October
	Related Industry News Consort Medical feeling the loss of Exubera Consort Medical's UK operations may be in line for more job losses as further collateral damage from Pfizer's withdrawal of Exubera from the market... Read Flamel tech used for Merck Serono drug France-based Flamel Technologies and Merck Serono have shook hands on a new €2m ($2.9m) deal which would see Flamel's Medusa technology used to develop an extended-release profile of an undisclosed therapeutic... Read MDS Pharma continues efforts to move on from FDA review MDS Pharma is continuing its efforts to move on from the trouble caused in its Pharma Services segment by a US Food and Drug Administration (FDA) review of its Montreal-area bioanalytical facilities... Read Merck inks multi-million dollar deal with Cognizant Merck & Co. has just inked "multi-million dollar" deal with Cognizant, at a time when the US-based IT services firm is pursuing a greater presence in the life sciences sector... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Previous Headlines French CROs have eye on niche market Two French contract research organisations (CROs) that specialise in ophthalmology have banded together to offer specialised services to this niche market... Read NIH cash for new tools to unravel genome's secrets The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse... Read Affymetrix simplifies genetic copy number analysis Affymetrix has launched a new analysis tool for determining genetic variations in whole-genome association and cytogenetic studies that is up to 10 times more sensitive than competing software... Read Drugs moving into the clinic: 39 The last in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read Oxford Genome Sciences advances on Amgen deal Oxford Genome Sciences (OGeS) has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one of the world's largest biotech... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com